VMC
77
-3
USB
62
-3
CINF
45
-3
V
42
-2
DVA
59
3
CMA
56
-3
ICE
48
-2
NTRS
64
17
KEY
57
-3
YUM
65
2
PSX
59
4
MU
66
-2
FSLR
64
12
PSA
40
3
ETN
57
-2
ADM
68
12
WHR
46
-2
MCO
59
-3
DG
33
-3
ITW
40
-2
VMC
77
-3
USB
62
-3
CINF
45
-3
V
42
-2
DVA
59
3
CMA
56
-3
ICE
48
-2
NTRS
64
17
KEY
57
-3
YUM
65
2
PSX
59
4
MU
66
-2
FSLR
64
12
PSA
40
3
ETN
57
-2
ADM
68
12
WHR
46
-2
MCO
59
-3
DG
33
-3
ITW
40
-2
Financhill
Back

New York Times Co. - Ordinary Shares - Class A Vs. Regencell Bioscience Holdings Industry Stock Comparison

Buy
74

NYT
New York Times Co. - Ordinary Shares - Class A

Last Price:
$60.12
Seasonality Move:
-0.8%
Sell
25

RGC
Regencell Bioscience Holdings

Last Price:
$13.09
Seasonality Move:
33.33%
Buy
74
New York Times Co. - Ordinary Shares - Class A (NYT) is a Buy

Is New York Times Co. - Ordinary Shares - Class A a Buy, Sell or Hold?

  • The current New York Times Co. - Ordinary Shares - Class A [NYT] share price is $60.16. The Score for NYT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • NYT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Regencell Bioscience Holdings (RGC) is a Sell

Is Regencell Bioscience Holdings a Buy, Sell or Hold?

  • The current Regencell Bioscience Holdings [RGC] share price is $13.12. The Score for RGC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • RGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NYT Stock Price Chart

What is New York Times Co. - Ordinary Shares - Class A's stock price today?

  • The New York Times Co. - Ordinary Shares - Class A share price today is $60.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing slight selling pressure.

RGC Stock Price Chart

What is Regencell Bioscience Holdings's stock price today?

  • The Regencell Bioscience Holdings share price today is $13.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGC is experiencing buying pressure, which is a positive indicator for future bullish movement.

NYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 14.78 Buy
Relative Strength Index (14 RSI): 64.65 Buy
Chaikin Money Flow: -491652 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.99 - 58.23) Buy
Bollinger Bands (100): (50.34 - 56.88) Buy

RGC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.14 Sell
Relative Strength Index (14 RSI): 44.93 Sell
Chaikin Money Flow: 153369 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.14 - 14.66) Sell
Bollinger Bands (100): (0.19 - 24.67) Buy

NYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.27 Buy
20-day SMA: 55.31 Buy
50-day SMA: 55.38 Buy
200-day SMA: 52.94 Buy
8-day EMA: 57.04 Buy
20-day EMA: 43.36 Buy
50-day EMA: 24.38 Buy
200-day EMA: 7.38 Buy

RGC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.24 Sell
20-day SMA: 13.73 Sell
50-day SMA: 19.2 Sell
200-day SMA: 6.31 Buy
8-day EMA: 13.28 Sell
20-day EMA: 14.12 Sell
50-day EMA: 15.17 Sell
200-day EMA: 8.86 Buy

New York Times Co. - Ordinary Shares - Class A Earnings Growth & NYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.04 per share, an increase this year of $0.41 per share, and an increase next year of $0.18 per share.

Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

New York Times Co. - Ordinary Shares - Class A Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regencell Bioscience Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):